Two psychedelics companies have announced they’ll be collaborating to offer ketamine infusions in the US and psilocybin clinical retreats internationally with a special focus on  access needs for veterans. 

The present agreement was signed between Revitalist Lifestyle and Wellness Ltd. (OTCQB: RVLWF), a ketamine clinics owner and operator, and Wake Network, a biosciences company producing fungus-derived psilocybin and medicinal mushroom products through pharmaceutical-grade research.

Both psilocybin and ketamine have shown to improve depression, PTSD, suicidality, anxiety, and other conditions affecting the lives of many veterans. …

Full story available on Benzinga.com